NCPC(SH:600812) Jin Rong Jie·2025-08-05 20:22Group 1 - The stock price of North China Pharmaceutical closed at 6.83 yuan on August 5, 2025, down 0.87% from the previous trading day [1] - The company reported a trading volume of 201,300 lots and a transaction amount of 138 million yuan on the same day [1] - North China Pharmaceutical specializes in the research, production, and sales of chemical raw materials and formulations, covering various therapeutic areas including anti-infection, cardiovascular, vitamins, and nutritional health products [1] Group 2 - For the first half of 2025, the company expects to achieve a net profit of 123.5 million yuan, representing a year-on-year increase of 72% [1] - The anticipated growth in the mid-year report is primarily attributed to an increase in main business revenue and cost control [1] - The net profit attributable to shareholders of the listed company is expected to increase by approximately 51.52 million yuan year-on-year for the period of January to June [1] Group 3 - On August 5, 2025, the net outflow of main funds was 23.976 million yuan, with a cumulative net outflow of 107.8 million yuan over the past five trading days [1]